Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer
Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of chemotherapy combined
with autologous tumor Lysate-pulsed dendritic with cytokine-induced killer cell (Ag-D-CIK)
for gastric cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Shenzhen Hornetcorn Bio-technology Company, LTD
Collaborators:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University Affiliated Tumor Hospital of Guangzhou Medical University Jingzhou Central Hospital